Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…

Daniel G. Wilson net worth and biography

Daniel Wilson Biography and Net Worth

EVP of iRhythm Technologies

Daniel G. Wilson has served as iRhythm’s Executive Vice President of Strategy, Corporate Development and Investor Relations since June 2019. Previously, he served as Director and Head of Business Development at Penumbra, Inc., a global healthcare company focused on innovative therapies. Prior to Penumbra, he held various positions at J.P. Morgan over a 10-year tenure, most recently as Executive Director in the Healthcare Investment Banking group focused on digital health, medical technology and emerging healthcare companies. Earlier in his career, he held various positions in Piper Jaffray’s Healthcare Investment Banking group. He started his career at KPMG as an Audit Associate. Mr. Wilson has a B.S. in Business Administration from California Polytechnic State University at San Luis Obispo.

What is Daniel G. Wilson's net worth?: The estimated net worth of Daniel G. Wilson is at least $2.43 million as of February 29th, 2024. Mr. Wilson owns 32,967 shares of iRhythm Technologies stock worth more than $2,430,987 as of November 21st. This net worth approximation does not reflect any other investments that Mr. Wilson may own. Additionally, Mr. Wilson receives an annual salary of $670,090.00 as EVP at iRhythm Technologies. Learn More about Daniel G. Wilson's net worth.
How old is Daniel G. Wilson?: Mr. Wilson is currently 42 years old. There are 6 older executives and no younger executives at iRhythm Technologies. The oldest executive at iRhythm Technologies is Mr. Marc Rosenbaum, Senior VP of Finance & Chief Accounting Officer, who is 52 years old. Learn More on Daniel G. Wilson's age.
What is Daniel G. Wilson's salary?: As the EVP of iRhythm Technologies, Inc., Mr. Wilson earns $670,090.00 per year. There are 4 executives that earn more than Mr. Wilson. The highest earning executive at iRhythm Technologies is Mr. Quentin S. Blackford, President, CEO & Director, who commands a salary of $1,420,000.00 per year. Learn More on Daniel G. Wilson's salary.
How do I contact Daniel G. Wilson?: The corporate mailing address for Mr. Wilson and other iRhythm Technologies executives is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. iRhythm Technologies can also be reached via phone at (415) 632-5700 and via email at [email protected]. Learn More on Daniel G. Wilson's contact information.
Has Daniel G. Wilson been buying or selling shares of iRhythm Technologies?: Daniel G. Wilson has not been actively trading shares of iRhythm Technologies within the last three months. Most recently, Daniel G. Wilson sold 1,261 shares of the business's stock in a transaction on Thursday, February 29th. The shares were sold at an average price of $121.96, for a transaction totalling $153,791.56. Following the completion of the sale, the executive vice president now directly owns 32,967 shares of the company's stock, valued at $4,020,655.32. Learn More on Daniel G. Wilson's trading history.
Who are iRhythm Technologies' active insiders?: iRhythm Technologies' insider roster includes C. Bairey Merz (Director), Quentin Blackford (CEO), Mark Day (EVP), Douglas Devine (CFO), Patrick Murphy (EVP), Chad Patterson (Chief Commercial Officer), Sumi Shrishrimal (EVP, Chief Risk Officer), Mervin Smith (EVP of Business Operations), Minang Turakhia (Chief Medical Officer, Chief Scientific Officer and EVP, Product Innovation), David Vort (EVP), and Daniel Wilson (EVP). Learn More on iRhythm Technologies' active insiders.
Are insiders buying or selling shares of iRhythm Technologies?: In the last year, iRhythm Technologies insiders bought shares 2 times. They purchased a total of 6,944 shares worth more than $521,860.64. In the last year, insiders at the sold shares 12 times. They sold a total of 66,532 shares worth more than $6,937,400.34. The most recent insider tranaction occured on November, 4th when Director Abhijit Y Talwalkar bought 6,664 shares worth more than $500,866.24. Insiders at iRhythm Technologies own 0.7% of the company. Learn More about insider trades at iRhythm Technologies.
Information on this page was last updated on 11/4/2024.

Daniel G. Wilson Insider Trading History at iRhythm Technologies

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/29/2024	Sell	1,261	$121.96	$153,791.56	32,967
1/2/2024	Sell	7,218	$103.31	$745,691.58	26,629
3/29/2023	Sell	4,000	$125.00	$500,000.00	35,337
2/28/2023	Sell	1,726	$117.84	$203,391.84	40,759
9/26/2022	Sell	3,000	$122.57	$367,710.00	34,562
7/5/2022	Sell	1,428	$108.93	$155,552.04	37,562
3/4/2022	Sell	1,331	$132.67	$176,583.77
2/17/2022	Sell	2,652	$120.99	$320,865.48

Daniel G. Wilson Buying and Selling Activity at iRhythm Technologies

iRhythm Technologies Company Overview

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Today's Range

Now: $73.74

$72.36

$75.15

50 Day Range

MA: $72.82

$57.07

$89.50

2 Week Range

Now: $73.74

$55.92

$124.11

Volume

558,042 shs

Average Volume

613,413 shs

Market Capitalization

$2.31 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.23

Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

From Colonial Metals | Ad

Claim your FREE 2024 Gold Guide

Daniel Wilson Biography and Net Worth

What is Daniel G. Wilson's net worth?

How old is Daniel G. Wilson?

What is Daniel G. Wilson's salary?

How do I contact Daniel G. Wilson?

Has Daniel G. Wilson been buying or selling shares of iRhythm Technologies?

Who are iRhythm Technologies' active insiders?

Are insiders buying or selling shares of iRhythm Technologies?